No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Advair is a respiratory drug used to treat asthma and chronic obstructive pulmonary disease (COPD). It is a combination of two drugs, fluticasone and salmeterol, which work together to reduce inflammation and open up the airways. Advair is a long-acting bronchodilator, meaning it helps to keep the airways open for up to 12 hours. It is available in both inhaler and diskus form, and is typically prescribed for long-term maintenance of asthma and COPD.
Advair is one of the most widely prescribed respiratory drugs on the market, and is used by millions of people worldwide. It is a popular choice for those with asthma and COPD, as it is effective in controlling symptoms and reducing the risk of exacerbations.
Some of the companies in the Advair market include GlaxoSmithKline, Merck, AstraZeneca, and Boehringer Ingelheim. Show Less Read more
